Skip to content
healthcare.dev

Doxazosin

NDC 70771-1114, Doxazosin, tablet, from Zydus Lifesciences Limited.

Product NDC
70771-1114
Status
Listed
Labeler
Zydus Lifesciences Limited
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA208719
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1114 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DOXAZOSIN MESYLATE4 mg/1

Pharmacologic classes

Adrenergic alpha-Antagonists [MoA]; alpha-Adrenergic Blocker [EPC]

Package NDCNDC-11Package
70771-1114-0707711114001000 TABLET in 1 BOTTLE (70771-1114-0)
70771-1114-170771111401100 TABLET in 1 BOTTLE (70771-1114-1)
70771-1114-37077111140330 TABLET in 1 BOTTLE (70771-1114-3)
70771-1114-47077111140410 BLISTER PACK in 1 CARTON (70771-1114-4) / 10 TABLET in 1 BLISTER PACK (70771-1114-2)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ac889877-133c-4448-af5a-d77b3cbfe878

Use it

Look up 70771-1114 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1114 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70771-1114. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.